TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Elderly and Younger Patients Have Similar Outcomes Following Radioembolization July 26, 2013
TCL Archive Finasteride Improved Performance Of PSA In Prostate Cancer Prevention Trial August 25, 2006
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
